Gary Vincent Desir MD
Paul B. Beeson Professor of Medicine Chairman, Internal Medicine, Yale University School of Medicine
Join to View Full Profile
950 Campbell AveWest Haven, CT 06516
Phone+1 203-932-5711
Dr. Desir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Nephrology, 1986 - 1987- Yale-New Haven Medical CenterResidency, Internal Medicine, 1980 - 1984
Yale School of MedicineClass of 1980
Certifications & Licensure
CT State Medical License 1982 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- Acute kidney injury markers in pediatric pancreatitis: Differentiating disease states and assessing severity.Vineet Garlapally, Xiaojia Guo, Lindsey Hornung, Kenneth Delgado, Zobeida Cruz-Monserrate
Journal of Pediatric Gastroenterology and Nutrition. 2025-12-12 - 1 citationsVisceral pain-related acute actions of cerulein on mouse and human sensory neurons.Sachin Goyal, Nesia Zurek, Reza Ehsanian, Shivali Goyal, David T Jones
Molecular Pain. 2025-06-16 - Association between plasma catecholamine concentration and mortality in hospitalized adults with COVID-19: a secondary analysis of a multicenter randomized trial.Basmah Safdar, Gary Desir, Bin Zhou, Yanhong Deng, Xiaojia Guo
Critical Care. 2025-05-08
Press Mentions
Yale School of Medicine Reflects on Takeaways from COVID-19 ResponseSeptember 18th, 2024- Covid Pitch Sounds an AlarmApril 1st, 2021
- Deborah Dyett Desir, MD, Joins ACR Executive Committee as SecretaryNovember 22nd, 2020
Grant Support
- Development of a novel renalase agonist for the treatment of acute pancreatitisBESSOR PHARMA, LLC2016–2028
- New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonistsBESSOR PHARMA, LLC2023–2025
- Renalase In Acute Kidney Injury: Utility As A Biomarker, And Therapeutic AgentNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Renalase Deficiency And Cardiovascular Complications Of Chronic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- The Molecular Physiology Of RenalaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
